What is the ROE (Return on Equity) of Saniona this year?
The ROE of Saniona this year is 4.37 undefined.
Saniona ROE 2024
Saniona ROE
4.37
Ticker
SANION.ST
ISIN
SE0005794617
WKN
A110VV
In 2024, Saniona's return on equity (ROE) was 4.37, a -208.79% increase from the -4.01 ROE in the previous year.
Saniona Aktienanalyse
What does Saniona do?
Saniona AB is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutics for rare diseases. The company was previously known as Saniona AB (until 2014) and NeuroNova AB (until 2012). It was founded in Copenhagen, Denmark, in 2006 and quickly expanded to other countries. In 2013, the company opened an office in Boston, USA, to expand its activities in North America. Saniona AB is listed on the NASDAQ Stockholm and currently has over 60 employees worldwide. The company's business model revolves around discovering and developing drugs for rare diseases that have little to no existing therapies. They use a proprietary technology platform called Ion Channels and G Protein-Coupled Receptors (GPCRs) to identify novel compounds that could meet these urgent medical needs. Saniona AB aims to develop successful medications and sell them either through partnerships or their own marketing activities. The company operates in various areas, including rare diseases, the nervous system (developing drugs for movement disorders and psychiatric disorders), and diabetes and obesity. Saniona AB has several drug candidates in its pipeline targeting different therapeutic applications, with some in various stages of clinical development. One of its key products is Tesomet, a candidate for the treatment of Prader-Willi syndrome and hypothalamic-pituitary hormone disorders, which is currently in Phase 3 of clinical development. Another important candidate is AN788, being investigated in Phase 2 clinical studies for the treatment of idiopathic pulmonary fibrosis. In conclusion, Saniona AB is an emerging biopharmaceutical company developing innovative drugs for rare diseases. With a specialization in researching rare diseases with significant medical needs and unmet treatment options, the company utilizes a proprietary technology platform to identify new compounds that aim to fulfill these medical needs. With multiple drug candidates in development and a strong partnership strategy, Saniona is well-positioned to maximize the potential of its innovative therapies and benefit patients in need. Saniona ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Saniona's Return on Equity (ROE)
Saniona's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Saniona's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Saniona's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Saniona’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Saniona stock
How has the Return on Equity (ROE) of Saniona developed compared to the previous year?
The ROE of Saniona has increased by -208.79% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Saniona?
A high ROE indicates that Saniona generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Saniona?
A low ROE can indicate that Saniona is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Saniona affect the company?
A change in ROE (Return on Equity) of Saniona can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Saniona?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Saniona?
Some factors that can influence Saniona's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Saniona pay?
Over the past 12 months, Saniona paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Saniona is expected to pay a dividend of 0 SEK.
What is the dividend yield of Saniona?
The current dividend yield of Saniona is .
When does Saniona pay dividends?
Saniona pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Saniona?
Saniona paid dividends every year for the past 0 years.
What is the dividend of Saniona?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Saniona located?
Saniona is assigned to the 'Health' sector.
Wann musste ich die Aktien von Saniona kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Saniona from 7/27/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 7/27/2024.
When did Saniona pay the last dividend?
The last dividend was paid out on 7/27/2024.
What was the dividend of Saniona in the year 2023?
In the year 2023, Saniona distributed 0 SEK as dividends.
In which currency does Saniona pay out the dividend?
The dividends of Saniona are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Saniona
Our stock analysis for Saniona Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Saniona Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
